Skip to Main Content

Paper Details

Efficacy, safety and tolerability of imeglimin in patients with type⿿2 diabetes mellitus: A meta-analysis of randomized controlled trials.
0
2023
HbA1c, Imeglimin, chronic kidney disease, glycated hemoglobin, imeglimin, patients, type2 diabetes mellitus
Author NameAffiliation
Hirotaka WatadaJuntendo University Graduate School of Medicine
Kohei KakuKawasaki Medical School
  • 1 - 2

Datasets

Release 1.2